去纤苷国内有吗?
It is an intravenous injection that was approved by the European Union on October 22, 2013 for the treatment of hepatic veno-occlusive disease (VOD).
On March 30, 2016, the U.S. Food and Drug Administration (FDA) approved defibrotide for the treatment of hepatic veno-occlusive disease (VOD) secondary to hematopoietic stem cell transplantation in adults and children with renal and pulmonary dysfunction. The drug is the first and only treatment for severe hepatic veno-occlusive disease. This disease is rare and seriously life-threatening. Is defibrotide available in China?
Purchasing channels for defibrotide: According to Medical Companion Travel, defibrotide has not yet been launched in mainland China and is not on display for sale. However, it has been launched abroad. The price of defibrotide listed abroad is about 22,000. Due to the floating exchange rate, the price is different. Please consult Medical Companion Travel for specific prices! If you need defibrotide and it is inconvenient to go abroad, the most reliable way is to purchase it through a regular domestic overseas medical service institution, which will sign a guarantee contract for you. The medicine and money will not be handled by you, and will be mailed to the patient by direct mail, guaranteeing 100% authenticity!
Hepatic veno-occlusive disease is a condition in which some blood vessels in the liver are blocked, causing edema and reduced blood flow in the liver. This condition can lead to the most severe liver damage. In the most severe form of hepatic veno-occlusive disease, patients may develop renal and pulmonary failure.
Hepatic veno-occlusive disease is one of the serious complications after hematopoietic stem cell transplantation (HSCT), and the mortality rate in patients with severe HVOD can be as high as 100%.
Defibrotide is a single-stranded oligonucleotide mixture that has anti-thrombotic and fibrinolytic effects. In recent years, multiple clinical research results have shown that it is a safe and effective drug for preventing and treating VOD after HSCT.
Recommended related hot articles: /newsDetail/74884.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)